IgniteData Secures $11M in Oversubscribed Series A Funding

Why It Matters

The new capital speeds the rollout of AI‑driven automation in clinical trials, which can shorten drug‑development timelines and lower operational costs, underscoring growing investor confidence in health‑tech solutions.

Deal Summary

IgniteData announced the final close of its Series A round, raising a total of $11 million. The round was led by FCA Venture Partners with Labcorp Venture Fund and Epsilon anchoring the close, alongside existing investors SpringTide and Oncology Ventures. The capital will fund global expansion and AI‑powered product development.